Tinzaparin: considerations for use in clinical practice.

about

Venous thromboembolic disease

P2860

Q24631121-6466FDC7-1326-4D8C-9E14-567F1585F7A2

P2860

Tinzaparin: considerations for use in clinical practice.

Item

http://www.wikidata.org/entity/Q35591002

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Tinzaparin: considerations for use in clinical practice.

@ast

Tinzaparin: considerations for use in clinical practice.

@en

type

Item

label

Tinzaparin: considerations for use in clinical practice.

@ast

Tinzaparin: considerations for use in clinical practice.

@en

prefLabel

Tinzaparin: considerations for use in clinical practice.

@ast

Tinzaparin: considerations for use in clinical practice.

@en

P1476

Tinzaparin: considerations for use in clinical practice.

@en

P2093

Christina W Rivers

http://www.w3.org/2001/XMLSchema#string

Edith A Nutescu

http://www.w3.org/2001/XMLSchema#string

Helen Feinstein

http://www.w3.org/2001/XMLSchema#string

Nancy L Shapiro

http://www.w3.org/2001/XMLSchema#string

P2860

Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial

Cost comparison of tinzaparin versus enoxaparin as deep venous thrombosis prophylaxis in spinal cord injury: preliminary data.

Dosing and monitoring of low-molecular-weight heparins in special populations.

Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty.

Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients.

Low-molecular-weight heparins in the treatment of deep-vein thrombosis.

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

Low-molecular-weight heparins.

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-Novo.

P304

1831-1840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1345/APH.1D221

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8994788

http://www.w3.org/2001/XMLSchema#string

P698

14632588

http://www.w3.org/2001/XMLSchema#string

Tinzaparin: considerations for use in clinical practice.

about

P2860

P2860

Tinzaparin: considerations for use in clinical practice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698